Meetings

Efficacy and Safety of Liraglutide 3.0 Mg in Adult Overweight and Obese Weight Loss Responders without Diabetes: Results of the Randomised, Double-Blind, Placebo-Controlled 56-Week Scale Obesity and Prediabetes Trial
Patrick M. O'Neil, Ken Fujioka, Rafael Violante Ortiz, Birgitte Claudius, Christine Bjørn Jensen and Arne Astrup

Improvement in Binge Eating Following Liraglutide Therapy Is Accompanied By a Drop in Salivary Cortisol Levels
Sarah Anne Robert, Rohana Abdul Ghani, Suehazlyn Zainudin, Shamsul Azhar Shah, Wan Nazaimoon Wan Mohamud and Nor Azmi Kamaruddin

Liraglutide Increased Postprandial Insulin Secretion with Improvement in Glucose Levels in Non-Diabetic Obese Subjects: Potential for Diabetes Prevention
Sarah Anne Robert, Rohana Abdul Ghani, Suehazlyn Zainudin, Shamsul Azhar Shah, Wan Nazaimoon Wan Mohamud and Nor Azmi Kamaruddin

Cardiovascular Safety of Liraglutide: Meta-Analysis of Major Adverse Cardiovascular Events Across Weight Management and T2D Development Programs
Neil Poulter, Stephen Bain, Ian Caterson, Jorge Luiz Gross, Jason Hatch, John House, Adam Salisbury, Anne Bloch Thomsen, Christine Bjørn Jensen and Steven Marso

Early Weight Loss with Liraglutide 3.0 Mg As an Adjunct to Diet and Exercise Predicts 1-Year Weight Loss
Ken Fujioka, Richard Mauritz Bergenstal, Matthias Blüher, Ralph DeFronzo, Alfredo Halpern, Robert Kushner, Carel W Le Roux, Ofri Mosenzon, Patrick M. O'Neil, Trine Vang Skjøth, Christine Bjørn Jensen and Melanie Davies

Metformin Enhanced Weight Loss at 12 Months in EMPOWIR (Enhance the Metabolic Profile of Women with Insulin Resistance): A Randomized Trial of Normoglycemic Women with Midlife Weight Gain
Harriette Rosen Mogul, Ruth G Freeman and Khoa Nguyen

Carbohydrate Modified Diet and Insulin Sensitizers Decrease Visceral Adipose Tissue at 12 Months in EMPOWIR (Enhance the Metabolic Profile of Women with Insulin Resistance (NCT00618071); A Randomized Clinical Trial of Women with Midlife Weight Gain and Hyperinsulinemia
Ruth G Freeman, Harriette Rosen Mogul and Khoa Nguyen

Effect of Orlistat in Obese Veterans at the Brooklyn VA Hospital, Correlation with Weight Loss and Renal Dysfunction
Bhavana Bajracharya, Deep Shikha, Miriam Cohen and Morana Poljak-Varenika

Improvement of Metabolic Syndrome (Mets) Parameters in 237 Obese Hypogonadal Men upon Long-Term Treatment with Testosterone Undecanoate (TU) Injections: Observational Data from a Registry Study
Farid Saad, Ahmad Haider, Karim Sultan Haider, Gheorghe Doros and Abdulmaged M Traish

Weight Loss and Reduction of Waist Size in 237 Hypogonadal Men with Obesity Grades I-III Under Long-Term Treatment with Testosterone Undecanoate (TU): Observational Data from a Registry Study
Farid Saad, Ahmad Haider, Karim Sultan Haider, Gheorghe Doros and Abdulmaged M Traish